secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001641172-25-014622
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical shareholders approve increase in authorized common shares to 120M; Series I options become exercisable
--------------------------------------------------------------------------------

- Authorized common shares increased from 61M to 120M; total authorized shares now 121M (including 1M preferred).
- Stockholders approved issuance of Series I options (12,206,578 shares at $2.13) and placement agent options (305,164 shares at $2.6625); now immediately exercisable.
- Amendment to 2020 Omnibus Performance Award Plan approved, adding 2,591,019 authorized shares.
- Class I directors elected: Harel Gadot, Martin Madden, Tal Wenderow; each received >3M votes for.
- Brightman Almagor Zohar & Co. ratified as independent auditor for FY2025 with 13.2M votes in favor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000164117225014622/0001641172-25-014622-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000164117225014622/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-014622

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer